Materiobiology-Guided Regulation Of Mesenchymal Stromal Cell Fate For Aging-Related Diseases: From Basic Parameter Design To Clinical Application
Imagine having specialized cells in your body that are like tiny repair crews, ready to fix damage and regenerate tissues. These are called mesenchymal stromal cells (MSCs), and they hold immense promise for treating a wide range of diseases, particularly those linked to aging. However, using these cells in therapies has faced challenges; for instance, they often don’t survive long enough in the body, don’t go where they’re needed, or lose their effectiveness as they age, a process known as cellular senescence.
But what if we could guide these cellular repair crews more effectively? This is where “materiobiology” comes in—a field focused on designing smart materials to influence cell behavior. Researchers are exploring how to engineer biomaterials with specific physical properties, like stiffness or texture, or chemical cues, such as surface coatings or the release of beneficial molecules, to direct MSCs.
By carefully designing these materials, we can overcome the limitations of current MSC therapies. For aging-related conditions, this means creating environments that help MSCs combat issues like harmful reactive oxygen species (unstable molecules that can damage cells), regulate their genetic activity (epigenetic regulation), and protect their telomeres (caps on chromosomes that shorten with age). This approach aims to keep MSCs healthy, functional, and targeted to specific problems.
This innovative strategy could lead to more effective treatments for common aging-related diseases, including fibrosis (scarring of tissues), osteoarthritis (joint degeneration), heart failure, and chronic wound healing. By understanding and controlling how MSCs interact with their material surroundings, we are paving the way for a new generation of cell-based therapies that could significantly improve health in an aging population.
Source: link to paper